{"entity":{"type":"insider","cik":"0001314902","url":"/insider/0001314902","json_url":"/insider/0001314902.json","name":"Hislop Colin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2010-08-20","last":"2017-10-23","span_basis":"filed_date"},"name_variants":[{"name":"Hislop Colin","source":"filing","n_filings":8,"first_seen":"2010-08-20","last_seen":"2017-10-23"}],"transactions":[{"id":4493894,"accession":"0001209191-17-057762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-057762","line_url":"/filing/0001209191-17-057762#line-1","is_derivative":false,"issuer_cik":"0001314902","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001314902","owner_cik":"0001314902","owner_name":"Hislop Colin","owner_display_name":"Hislop Colin","owner_url":"/insider/0001314902","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":667.0,"shares_display":"667","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":1700.85,"total_display":"1,700.85","total_whole":"1,701","shares_owned_after":23833.0,"shares_owned_after_display":"23,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-19","filed_date":"2017-10-23","scope":"insider"},{"id":4830462,"accession":"0001209191-17-025821","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-025821","line_url":"/filing/0001209191-17-025821#line-2","is_derivative":false,"issuer_cik":"0001314902","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001314902","owner_cik":"0001314902","owner_name":"Hislop Colin","owner_display_name":"Hislop Colin","owner_url":"/insider/0001314902","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":21.2,"price_display":"21.20","price_state":"stated","total_value":742000.0,"total_display":"742,000.00","total_whole":"742,000","shares_owned_after":24500.0,"shares_owned_after_display":"24,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-05","scope":"insider"},{"id":8946838,"accession":"0001214659-15-007879","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-15-007879","line_url":"/filing/0001214659-15-007879#line-2","is_derivative":false,"issuer_cik":"0001314902","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001314902","owner_cik":"0001314902","owner_name":"Hislop Colin","owner_display_name":"Hislop Colin","owner_url":"/insider/0001314902","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":5.3073,"price_display":"5.31","price_state":"stated","total_value":66341.25,"total_display":"66,341.25","total_whole":"66,341","shares_owned_after":19147.0,"shares_owned_after_display":"19,147","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-13","filed_date":"2015-11-18","scope":"insider"},{"id":8701692,"accession":"0001214659-15-007703","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-15-007703","line_url":"/filing/0001214659-15-007703#line-1","is_derivative":false,"issuer_cik":"0001314902","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001314902","owner_cik":"0001314902","owner_name":"Hislop Colin","owner_display_name":"Hislop Colin","owner_url":"/insider/0001314902","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":5.38,"price_display":"5.38","price_state":"stated","total_value":26900.0,"total_display":"26,900.00","total_whole":"26,900","shares_owned_after":19147.0,"shares_owned_after_display":"19,147","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-11","filed_date":"2015-11-12","scope":"insider"},{"id":3463769,"accession":"0001104659-12-007031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-007031","line_url":"/filing/0001104659-12-007031#line-1","is_derivative":false,"issuer_cik":"0001314902","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001314902","owner_cik":"0001314902","owner_name":"Hislop Colin","owner_display_name":"Hislop Colin","owner_url":"/insider/0001314902","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":246000.0,"total_display":"246,000.00","total_whole":"246,000","shares_owned_after":27967.0,"shares_owned_after_display":"27,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-03","filed_date":"2012-02-06","scope":"insider"},{"id":9011359,"accession":"0001104659-11-063254","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-11-063254","line_url":"/filing/0001104659-11-063254#line-2","is_derivative":false,"issuer_cik":"0001314902","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001314902","owner_cik":"0001314902","owner_name":"Hislop Colin","owner_display_name":"Hislop Colin","owner_url":"/insider/0001314902","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":6.7442,"price_display":"6.74","price_state":"stated","total_value":101163.0,"total_display":"101,163.00","total_whole":"101,163","shares_owned_after":57967.0,"shares_owned_after_display":"57,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-08","filed_date":"2011-11-10","scope":"insider"},{"id":9123612,"accession":"0001209191-11-009478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-009478","line_url":"/filing/0001209191-11-009478#line-1","is_derivative":false,"issuer_cik":"0001314902","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001314902","owner_cik":"0001314902","owner_name":"Hislop Colin","owner_display_name":"Hislop Colin","owner_url":"/insider/0001314902","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3894.0,"shares_display":"3,894","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":50062.0,"shares_owned_after_display":"50,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-11","filed_date":"2011-02-14","scope":"insider"},{"id":7693994,"accession":"0001209191-10-043510","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-043510","line_url":"/filing/0001209191-10-043510","is_derivative":false,"issuer_cik":"0001314902","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001314902","owner_cik":"0001314902","owner_name":"Hislop Colin","owner_display_name":"Hislop Colin","owner_url":"/insider/0001314902","role":"Officer (Sr. VP, Cardiovasc. Prod)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Cardiovasc. Prod)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Cardiovasc. Prod.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.7996,"price_display":"4.80","price_state":"stated","total_value":2399.8,"total_display":"2,399.80","total_whole":"2,400","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-18","filed_date":"2010-08-20","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001513818","name":"Versartis, Inc.","url":"/issuer/0001513818","role":"Officer (Chief Medical Officer)","n_filings":2,"first_seen":"2017-04-05","last_seen":"2017-10-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001316175","name":"Anthera Pharmaceuticals Inc","url":"/issuer/0001316175","role":"Officer (Chief Medical Officer)","n_filings":6,"first_seen":"2010-08-20","last_seen":"2015-11-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001314902","retrieved_at":"2026-08-23T03:41:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}